Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul 17:4:7.
doi: 10.5772/61186. eCollection 2015 Jan-Dec.

Exosomes: Mechanisms of Uptake

Affiliations
Review

Exosomes: Mechanisms of Uptake

Kelly J McKelvey et al. J Circ Biomark. .

Abstract

Exosomes are 30-100 nm microvesicles which contain complex cellular signals of RNA, protein and lipids. Because of this, exosomes are implicated as having limitless therapeutic potential for the treatment of cancer, pregnancy complications, infections, and autoimmune diseases. To date we know a considerable amount about exosome biogenesis and secretion, but there is a paucity of data regarding the uptake of exosomes by immune and non-immune cell types (e.g., cancer cells) and the internal signalling pathways by which these exosomes elicit a cellular response. Answering these questions is of paramount importance.

Keywords: Exosome; endocytosis; immunology.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic of exosome biogenesis, internalization and cellular response. The adhesion of exosomes to the recipient cell utilizes the interaction of various exosomal surface proteins and cellular receptors. Once bound, the exosome may (i) elicit transduction of the signal via intracellular signalling pathways and be released (juxtacrine signalling); (ii) fuse with the cellular membrane transferring protein and genetic contents, into the cytoplasm of the recipient cell (fusion); or (iii) be endocytosed via phagocytosis, macropinocytosis or receptor-mediated endocytosis. This figure was produced using Servier Medical Art, available from www.servier.com/Powerpoint-image-bank.

References

    1. Feynman R. (1960). There's plenty of room at the bottom. Eng. Sci. (CalTech), 23: 22–36.
    1. Whiteside T. (2013). Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem. Soc. Trans., 41: 245–251. - PMC - PubMed
    1. Pitt JM, Charrier M, Viaud S, André F, Besse B, Chaput N, Zitvogel L. (2014). Dendritic cell–derived exosomes as immunotherapies in the fight against cancer. J. Immunol., 193: 1006–1011. - PubMed
    1. Chaput N, Flament C, Viaud S, Taieb J, Roux S, Spatz A, André F, LePecq J-B, Boussac M, Garin J, Amigorena S, Théry C, Zitvogel L. (2006). Dendritic cell-derived exosomes: biology and clinical implementations. J. Leuko. Biol., 80: 471–478. - PubMed
    1. Quah BJ, O'Neill HC. (2005). The immunogenicity of dendritic cell-derived exosomes. Blood Cell. Mol. Dis., 35: 94–110. - PubMed